GlassScriptPhysician profile
Grigorios Lamaris
NPI 1265691166
$2,638.24
in general payments reported to CMS, 2019-2025
13 companies · $382 in 2025
The $382 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $509 · 2020: $64.49 · 2021: $266 · 2022: $156 · 2023: $551 · 2024: $710 · 2025: $382.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,642.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,642.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kls-Martin L.P. | $785.35 | 2022-2025 | |
| Axogen | $494.88 | 2021-2024 | Avance Nerve Graft, Axoguard Nerve Cap, Axoguard Ha+ Nerve Protector |
| Alafair Biosciences, INC. | $344.17 | 2019 | |
| Stryker Corporation | $186.69 | 2022-2024 | Spy-Phi System |
| Integra Lifesciences Corporation | $176.55 | 2022-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Baxter Healthcare | $161.92 | 2019-2023 | Artiss |
| Aroa Biosurgery Incorporated | $149.01 | 2023 | |
| Kci USA, INC. | $88.63 | 2020-2021 | |
| Polynovo North America LLC | $82.60 | 2022-2024 | Novosorb Btm |
| Depuy Synthes Sales INC. | $60.91 | 2019-2025 | Trumatch |
| Biocomposites INC | $44.31 | 2022 | |
| Mimedx Group, INC. | $42.17 | 2025 | |
| Olympus America INC. | $21.05 | 2025 | Orbeye Surgical Microscope |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Grigorios Lamaris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.